Denmark Archives - FinSMEs

Home » Denmark

Skip to content

FinSMEs

FinSMEs FinSMEs

REAL TIME VC & PRIVATE EQUITY DEALS AND NEWS

  • Facebook
  • Twitter
  • Linkedin
Navigation

Site navigation

  • USA
  • UK
  • Germany
  • Canada
  • China
  • Russia
  • India
  • France
  • Italy
  • NFT
  • Home
  • Denmark

Denmark

lun energy

Lun Energy Raises $11.2M in Seed Funding

Lun Energy, a Copenhagen, Denmark-based startup that aims to decarbonize homes, raised $11.2m in seed funding.

Published on March 24, 2023March 24, 2023By FinSMEs
tryp

Tryp.com Raises Seed Funding

Tryp.com, an Odense, South Denmark-based flights and hotels included searching company, raised an undisclosed amount in Seed funding, at a valuation of €8.3M.

Published on March 16, 2023By FinSMEs
QuadSAT

QuadSAT Raises €9M in Funding

QuadSAT, an Odense, Denmark-based company focused on verification of radio frequency equipment, raised €9M in funding.

Published on March 16, 2023March 16, 2023By FinSMEs
healthcare

Five companies Receive Financial Support Through BioInnovation Institute’s Venture House Program

BioInnovation Institute (BII), a Copenhagen, Denmark-based international non-profit foundation incubating and accelerating world-class life science research, provided additional financial support to five companies through its Venture House program.

Published on March 16, 2023March 16, 2023By FinSMEs
healthcare

Teitur Trophics Raises EUR 28M in Series A Financing

Teitur Trophics, an Aarhus, Denmark-based biotech company dedicated to developing treatments for patients suffering from neurodegenerative diseases, raised EUR 28M in Series A funding.

Published on March 14, 2023March 14, 2023By FinSMEs
Macarons-with-Natu.Red_

Chromologics Raises Additional €7.1M in Funding

Chromologics, a Copenaghen, Denmark-based biotech company specializing in production of natural food colors, raised additional €7.1M in funding.

Published on March 6, 2023March 6, 2023By FinSMEs
logpoint

Logpoint Receives Majority Investment from Summa Equity

Logpoint, a Copenhagen, Denmark-based creator of a cybersecurity operations platform, received a majority investment from Summa Equity.

Published on March 2, 2023March 2, 2023By FinSMEs
Hemab Therapeutics

Hemab Therapeutics Raises $135M in Series B Financing

Hemab Therapeutics, a Copenhagen, Denmark and Boston, MA-based clinical-stage biotechnology company developing prophylactic therapeutics for bleeding and thrombotic disorders, raised $135M in Series B funding.

Published on February 21, 2023February 21, 2023By FinSMEs
lunar

Lunar Raises EUR35M in Funding

Lunar, an Aarhus, Denmark-based challenger bank, raised €35m in funding.

Published on February 9, 2023February 9, 2023By FinSMEs
Reshape Biotech founders Carl-Emil Grøn Christensen, Magnus Madsen and Daniel Storgaard (Photo: Business Wire)

Reshape Bio Raises $8.1M in Funding

Reshape Biotech, a Copenhagen, Denmark-based provider of an integrated hardware and software platform digitizing microbiology experiments, raised $8.1M in funding.

Published on February 9, 2023February 9, 2023By FinSMEs
Mazepay

Mazepay Raises €4M in Growth Funding

Mazepay, a Copenhagen, Denmark-based fintech platform for long-tail procurement and B2B payments, raised €4M in Growth funding.

Published on February 8, 2023February 8, 2023By FinSMEs
Freightify

Freightify Raises $12M in Funding

Freightify, a Singapore-based digital freight forwarders company, raised $12M in debt & equity funding.

Published on February 2, 2023February 2, 2023By FinSMEs
easytranslate

EasyTranslate Closes €2.75M Funding

EasyTranslate, a Copenhagen, Denmark-based marketplace of freelance translators, raised €2.75M in funding.

Published on January 31, 2023By FinSMEs
Tetra Pharm Technologies

Tetra Pharm Technologies Raises €9M in Series A Funding

Tetra Pharm Technologies, a Copenhagen, Denmark-based biotech company focused on therapeutics targeting the endocannabinoid system, raised €9M in Series A funding.

Published on January 26, 2023January 26, 2023By FinSMEs
Ensoma

Ensoma Raises $85M in Series B Funding; Acquires Twelve Bio

Ensoma, a Boston, MA-based genomic medicines company developing one-time in vivo treatments that precisely engineer any cell of the hematopoietic system, raised $85M in Series B funding, and acquired Twelve Bio, a Copenhagen, Denmark-based CRISPR engineering company.

Published on January 10, 2023By FinSMEs

Posts navigation

← Older posts

The Daily Deal Newsletter – Sign Up

About | Advertise | Contact | Terms & Conditions | Disclaimer | News | The Daily Deal Newsletter

Privacy Policy
FinSMEs is owned by FinSMEs Ltd - 86 - 90 Paul Street - London, UK - EC2A 4NE - e-mail: [email protected]

Follow FinSMEs on: